TP53 and thyroid gland carcinoma: An in vivo study by Nagayama and colleagues on the role of p53 re-expression in thyroid cancer suppression using FRO cells (ATC) transfected with wild-type p53 highlighted the effect of this TSG on thyroid tumor-growth suppression.